It is really nice to see all of the positive activity on this board. Mr. Schneiderman set this all in motion according to his timing and his plan. For months we were all wondering when he would reach out to a larger investor's base. Well, it all started with the SeeThruEquity conference in New York where he was able to discuss SCRC with key investment groups. He then followed that up with an investors conference call at the beginning of this month. It was all about timing. He knew exactly when the best time was to begin his SCRC awareness program. On the conference he discussed several topics, one was the negotiations to complete a bank deal which resulted in securing a $4M line of credit. Next he discussed his goal of winning the PIMD licensing in New Jersey and the high level of urgency placed on accomplishing this. I believe in short order we will hear the results of efforts. Next he was very positive on being able to announcement completion of the RapiMeds launch in Hong Kong and the Asian markets in the very near future. He has demonstrated he keeps word and I can see these announcements coming out soon.
So let's talk about compounding. Q3 delivered incredible revenues which resulted in $1.2M cash in the bank. Based on October and November revenues I expect Q4 to be another huge success with a record breaking quarterly performance. Back to back Q3 and Q4 results are in my mind what investors are looking for to secure their confidence in SCRC as a solid long term investment. Is the confidence growing, you bet it is. Just look at the last two days with combined volume of close to 4M shares traded. I expect we will see fluctuation in the weeks to follow but the trend will be pointing North from this point on.
Over the past several months we have read comments from both sides of the fence. Honestly, even though I always tried to be positive there were times I didn't know what to think. But I never doubted Mr. Schneiderman's word to deliver results, and it is obvious right now he is making it happen. With cash in the bank, financing secured, the expanding success of compounding, NJ PIMD getting closer, and the imminent success of RapiMeds in the Asian market, the future for SCRC couldn't be brighter.
2015 is going to be explosive. GO SCRC!!!
